evERA Breast Cancer: A phase III study of giredestrant (GDC-9545) + everolimus vs exemestane plus everolimus in patients with estrogen receptor+, HER2-locally advanced or metastatic breast cancer
CANCER RESEARCH（2023）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要